Anti-SLIK1/ SLITRK1/ LRRC12 monoclonal antibody
Anti-SLIK1/ SLITRK1/ LRRC12 antibody for FACS & in-vivo assay
Go to SLITRK1/SLITRK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1683-Ab-1/ GM-Tg-hg-MP1683-Ab-2 | Anti-Human SLITRK1 monoclonal antibody | Human |
GM-Tg-rg-MP1683-Ab-1/ GM-Tg-rg-MP1683-Ab-2 | Anti-Rat SLITRK1 monoclonal antibody | Rat |
GM-Tg-mg-MP1683-Ab-1/ GM-Tg-mg-MP1683-Ab-2 | Anti-Mouse SLITRK1 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1683-Ab-1/ GM-Tg-cynog-MP1683-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SLITRK1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1683-Ab-1/ GM-Tg-felg-MP1683-Ab-2 | Anti-Feline SLITRK1 monoclonal antibody | Feline |
GM-Tg-cang-MP1683-Ab-1/ GM-Tg-cang-MP1683-Ab-2 | Anti-Canine SLITRK1 monoclonal antibody | Canine |
GM-Tg-bovg-MP1683-Ab-1/ GM-Tg-bovg-MP1683-Ab-2 | Anti-Bovine SLITRK1 monoclonal antibody | Bovine |
GM-Tg-equg-MP1683-Ab-1/ GM-Tg-equg-MP1683-Ab-2 | Anti-Equine SLITRK1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1683-Ab-1/ GM-Tg-hg-MP1683-Ab-2; GM-Tg-rg-MP1683-Ab-1/ GM-Tg-rg-MP1683-Ab-2; GM-Tg-mg-MP1683-Ab-1/ GM-Tg-mg-MP1683-Ab-2; GM-Tg-cynog-MP1683-Ab-1/ GM-Tg-cynog-MP1683-Ab-2; GM-Tg-felg-MP1683-Ab-1/ GM-Tg-felg-MP1683-Ab-2; GM-Tg-cang-MP1683-Ab-1/ GM-Tg-cang-MP1683-Ab-2; GM-Tg-bovg-MP1683-Ab-1/ GM-Tg-bovg-MP1683-Ab-2; GM-Tg-equg-MP1683-Ab-1/ GM-Tg-equg-MP1683-Ab-2 |
Products Name | Anti-SLITRK1 monoclonal antibody |
Format | mab |
Target Name | SLITRK1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SLITRK1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species SLIK1/ SLITRK1/ LRRC12 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP1683 |
Target Name | SLITRK1 |
Gene ID | 114798,76965,306147,699217,485509,101091497,615880,100050220 |
Gene Symbol and Synonyms | 3200001I04Rik,LRRC12,SLITRK1,T™ |
Uniprot Accession | Q96PX8 |
Uniprot Entry Name | SLIK1_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000178235 |
Target Classification | N/A |
The target: SLITRK1, gene name: SLITRK1, also named as LRRC12, T™. This gene encodes a member of the SLITRK protein family. Members of this family are integral membrane proteins that are characterized by two N-terminal leucine-rich repeat (LRR) domains and a C-terminal region that shares homology with trk neurotrophin receptors. However, the protein encoded by this gene lacks the region of homology to neurotrophin receptors. This protein is thought to be involved in neurite outgrowth. Mutations in this gene may be associated with Tourette syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.